ASPREE-XT (eXTension) study funded to determine longer-term effects of aspirin on health
FOR PARTICIPANTS: Important information about ASPREE-XT and Coronavirus (COVID-19)
In light of public health recommendations to help slow the spread of Coronavirus (COVID-19) in the community, ASPREE-XT will be temporarily replacing annual face-to-face study visits with a phone call. This decision, which took effect as of Monday 23rd March 2020, will continue until further notice.
We will be aiming to call each participant around the time that you are due for a face-to-face annual study visit to conduct as much of the study visit as possible over the phone. The call will take around 45 minutes.
The usual annual questionnaires, which ask about your wellbeing and physical ability, may be answered during the phone call. Thinking and memory exercises and physical measures, such as your blood pressure, will be on hold until we see you again in person.
It is unknown when face-to-face ASPREE-XT study visits will resume. In the meantime, please accept our sincere thanks in advance for contributing to ASPREE-XT health and ageing research via the phone.
If you need to contact ASPREE-XT please call your study center.
The entire ASPREE-XT team thanks you for your understanding and we look forward to seeing you in person, at study visits in the future.
If you would like to know more about the Coronavirus (COVID-19): https://www.cdc.gov/coronavirus/2019-ncov/index.html
25.03.2020
Related posts
